Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity
Open Access
- 28 June 2016
- journal article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 6 (1), 28861
- https://doi.org/10.1038/srep28861
Abstract
Ethoxyquin was recently identified as a neuroprotective compound against toxic neuropathies and efficacy was demonstrated against paclitaxel-induced neurotoxicity in vivo. In this study we examined the efficacy of ethoxyquin in preventing neurotoxicity of cisplatin in rodent models of chemotherapy-induced peripheral neuropathy and explored its mechanism of action. Ethoxyquin prevented neurotoxicity of cisplatin in vitro in a sensory neuronal cell line and primary rat dorsal root ganglion neurons. In vivo, chronic co-administration of ethoxyquin partially abrogated cisplatin-induced behavioral, electrophysiological and morphological abnormalities. Furthermore, ethoxyquin did not interfere with cisplatin’s ability to induce tumor cell death in ovarian cancer cell line in vitro and in vivo. Finally, ethoxyquin reduced the levels of two client proteins (SF3B2 and ataxin-2) of a chaperone protein, heat shock protein 90 (Hsp90) when co-administered with cisplatin in vitro. These results implied that the neuroprotective effect of ethoxyquin is mediated through these two client proteins of Hsp90. In fact, reducing levels of SF3B2 in tissue-cultured neurons was effective against neurotoxicity of cisplatin. These findings suggest that ethoxyquin or other compounds that inhibit chaperone activity of Hsp90 and reduce levels of its client protein, SF3B2 may be developed as an adjuvant therapy to prevent neurotoxicity in cisplatin-based chemotherapy protocols.Keywords
This publication has 24 references indexed in Scilit:
- Meta-analysis of gene expression profiles indicates genes in spliceosome pathway are up-regulated in hepatocellular carcinoma (HCC)Medical Oncology, 2015
- Heat shock protein 90 targeting therapy: state of the art and future perspective.2015
- RNA-Seq Reveals Spliceosome and Proteasome Genes as Most Consistent Transcripts in Human Cancer CellsPLOS ONE, 2013
- Inhibiting Heat-Shock Protein 90 Reverses Sensory Hypoalgesia in Diabetic MiceASN Neuro, 2010
- Immortalization and characterization of a nociceptive dorsal root ganglion sensory neuronal lineJournal of the Peripheral Nervous System, 2007
- Molecular Architecture of the Multiprotein Splicing Factor SF3bScience, 2003
- Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factorNeuroscience Letters, 2002
- Cisplatin NeurotoxicityThe New England Journal of Medicine, 1990
- Cisplatin in the Treatment of Solid Tumors: Effect of Dose and ScheduleJNCI Journal of the National Cancer Institute, 1989
- Toxic effects of cis-dichlorodiammineplatinum(II) in man.1979